{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:52:04Z","timestamp":1795045924223,"version":"4.10.2"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T00:00:00Z","timestamp":1291593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND AND PURPOSE<\/jats:bold>Frankincense, the gum resin derived from<jats:italic>Boswellia<\/jats:italic>species, showed anti\u2010inflammatory efficacy in animal models and in pilot clinical studies. Boswellic acids (BAs) are assumed to be responsible for these effects but their anti\u2010inflammatory efficacy<jats:italic>in vivo<\/jats:italic>and their molecular modes of action are incompletely understood.<\/jats:p><jats:p><jats:bold>EXPERIMENTAL APPROACH<\/jats:bold>A protein fishing approach using immobilized BA and surface plasmon resonance (SPR) spectroscopy were used to reveal microsomal prostaglandin E<jats:sub>2<\/jats:sub>synthase\u20101 (mPGES1) as a BA\u2010interacting protein. Cell\u2010free and cell\u2010based assays were applied to confirm the functional interference of BAs with mPGES1. Carrageenan\u2010induced mouse paw oedema and rat pleurisy models were utilized to demonstrate the efficacy of defined BAs<jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>KEY RESULTS<\/jats:bold>Human mPGES1 from A549 cells or<jats:italic>in vitro<\/jats:italic>\u2010translated human enzyme selectively bound to BA affinity matrices and SPR spectroscopy confirmed these interactions. BAs reversibly suppressed the transformation of prostaglandin (PG)H<jats:sub>2<\/jats:sub>to PGE<jats:sub>2<\/jats:sub>mediated by mPGES1 (IC<jats:sub>50<\/jats:sub>\u2003=\u20033\u201310\u2003\u00b5M). Also, in intact A549 cells, BAs selectively inhibited PGE<jats:sub>2<\/jats:sub>generation and, in human whole blood, \u03b2\u2010BA reduced lipopolysaccharide\u2010induced PGE<jats:sub>2<\/jats:sub>biosynthesis without affecting formation of the COX\u2010derived metabolites 6\u2010keto PGF<jats:sub>1\u03b1<\/jats:sub>and thromboxane B<jats:sub>2<\/jats:sub>. Intraperitoneal or oral administration of \u03b2\u2010BA (1\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>) suppressed rat pleurisy, accompanied by impaired levels of PGE<jats:sub>2<\/jats:sub>and \u03b2\u2010BA (1\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>, given i.p.) also reduced mouse paw oedema, both induced by carrageenan.<\/jats:p><jats:p><jats:bold>CONCLUSIONS AND IMPLICATIONS<\/jats:bold>Suppression of PGE<jats:sub>2<\/jats:sub>formation by BAs via interference with mPGES1 contribute to the anti\u2010inflammatory effectiveness of BAs and of frankincense, and may constitute a biochemical basis for their anti\u2010inflammatory properties.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.01020.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T14:36:44Z","timestamp":1284475004000},"page":"147-162","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Inhibition of microsomal prostaglandin E<sub>2<\/sub>synthase\u20101 as a molecular basis for the anti\u2010inflammatory actions of boswellic acids from frankincense"],"prefix":"10.1111","volume":"162","author":[{"given":"U","family":"Siemoneit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Koeberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Verhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Reckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TJ","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Northoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Doetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sautebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,6]]},"reference":[{"issue":"1","key":"e_1_2_8_2_1","first-page":"S1","article-title":"Guide to receptors and channels (GRAC), 4th edn","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947227"},{"key":"e_1_2_8_4_1","first-page":"L126","article-title":"Prostaglandin G\/H synthase\u20102 is the constitutive and dominant isoform in cultured human lung epithelial cells","volume":"271","author":"Asano K","year":"1996","journal-title":"Am J Physiol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(03)00555-5"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27540"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4738"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.294.5548.1871"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02024141"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm700952v"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403106200"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(82)90131-9"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.13.7220"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.200300386"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(96)00195-0"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00377-0"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986709789578178"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.139444"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00070.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018424"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2008.10.005"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-08-0154"},{"key":"e_1_2_8_23_1","first-page":"887","article-title":"Expression and regulation of microsomal prostaglandin E synthase\u20101 in human osteoarthritic cartilage and chondrocytes","volume":"32","author":"Li X","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(02)00043-6"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986706779010333"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089466"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.024836"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1297"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-3565(25)11130-0","article-title":"Boswellic acids: novel, specific, nonredox inhibitors of 5\u2010lipoxygenase","volume":"261","author":"Safayhi H","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-3565(24)36628-5","article-title":"Inhibition by boswellic acids of human leukocyte elastase","volume":"281","author":"Safayhi H","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.59.3.1"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.07.001"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2461"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.09.010"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.01.044"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.04.034"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2008.02.017"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2590315"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-835844"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.1.498"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803574"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01735.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1332766100"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606586103"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.05.009"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20286"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.138776"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.01020.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.01020.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:33:47Z","timestamp":1740515627000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.01020.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1476-5381.2010.01020.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01020.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,6]]},"assertion":[{"value":"2010-12-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}